DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Standard Medical Management in Secondary Prevention of Ischemic Stroke in China

Information source: Peking Union Medical College Hospital
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Stroke

Intervention: Aspirin / Clopidogrel, Atorvastatin / Simvastatin (Drug); Asprin / Clopidogrel, Atorvastatin / Simvastatin (Drug)

Phase: N/A

Status: Completed

Sponsored by: Peking Union Medical College Hospital

Official(s) and/or principal investigator(s):
Liying Cui, Principal Investigator, Affiliation: Peking Union Medical College Hospital

Summary

The purposes of the study are to analyse the cross-section data of secondary stroke prevention in China and to carry out a standard medical management including medicine and interactive education program,and to evaluate the efficacy and safety of the standard medical management in secondary stroke prevention.

Clinical Details

Official title: Standard Medical Management in Secondary Prevention of Ischemic Stroke in China.

Study design: Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention

Primary outcome: Success Rate of standard medical management

Secondary outcome:

Ischemic stroke

Non-fatal acute coronary syndrome

Transient Ischemic Attack

Hemorrhagic Stroke

All-cause Death

Eligibility

Minimum age: 18 Years. Maximum age: N/A. Gender(s): Both.

Criteria:

Inclusion Criteria: 1. Ischemic cerebral infarction or TIA within 30 days. 2. Aged above 18 years old. 3. Hospitalized. 4. Cranial CT or MRI scan exclude intracranial hemorrhagic diseases 5. Stable clinical and neurological conditions. 6. A Modified Rankin score less than 4 at enrollment 7. Informed consent is obtained. Exclusion Criteria: Patients will be excluded from entry if any of the criteria listed below are met 1. Documented stroke caused by conditions other than atherosclerosis, ie, surgical or vascular intervention procedure. 2. Severe co-morbid or unstable medical condition, ie, heart failure, respiratory failure and renal failure, severe liver dysfunction, malignancy with likelihood of death within the next 2 years 3. Significant memory or behavioural disorder, ie, Alzheimer disease, etc, daily care needed. 4. A Modified Rankin score is more than 4 5. Concurrent participation in another clinical trial 6. Pregnant 7. Unable to give informed consent.

Locations and Contacts

Beijing Daxing District Hospital, Beijing, Beijing, China

Beijing Ji Shui Tan Hospital,the 4Th Medical College of Peking University, Beijing, Beijing, China

Beijing Shijitan Hospital, Beijing, Beijing, China

Beijing Tiantan Hospital, Beijing, Beijing, China

China Pla General Hospital, Beijing, Beijing 100853, China

China Rehabilition Research Center, Beijing, Beijing, China

General Hospital of Navy, Beijing, Beijing, China

Luhe Hospital of Tongzhou Distict Beijing, Beijing, Beijing, China

No 263 Hospital of Pla, Beijing, Beijing, China

No 309 Hospital of Pla, Beijing, Beijing, China

Peking Union Medical College Hosptial, Beijing, Beijing 100730, China

Peking University Third Hospital, Beijing, Beijing, China

Pinggu County Hospital Beijing, Beijing, Beijing, China

Xuanwu Hospital Capital Medical University, Beijing, Beijing, China

Daping Hospital, Chongqing, Chongqing, China

Southwest Hospital, Chongqing, Chongqing, China

Guangzhou First Municipal People'S Hospital, Guangzhou, Guangdong, China

The First Affiliated Hospital,Sun Yat-Sen Unversity, Guangzhou, Guangdong, China

The First Hospital of Hebei Medical University, Shijiazhuang, Hebei, China

The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China

The Third Hospital of Hebei Medical University, Shijiazhuang, Hebei, China

Yutian County Hospital, Yutian, Hebei, China

Hebei North University, Zhangjiakou, Hebei, China

The First Hospital of Harbin Medical University, Harbin, Helongjiang, China

The Second Hospital of Harbin Medical University, Harbin, Helongjiang, China

Henan Provincial People'S Hospital, Zhengzhou, Henan, China

The Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China

Xiangya Hospital of Centre-South University, Changsha, Hunan, China

Inner Mongolia Baotou City Central Hospital, Baotou, Inner Mongolia, China

The Appurtenant Hospital of Chifeng University, Chifeng, Inner Mongolia, China

Jiangsu Province Hospital, Nanjing, Jiangsu, China

Nanjing General Hospital of Nanjing Military Command, Nanjing, Jiangsu, China

The Affiliated Drumtower Hospital of Nanjing University Medical School, Nanjing, Jiangsu, China

Jilin University, Changchun, Jilin, China

The Third People'S Hospital of Dalian, Dalian, Liaoning, China

The First Affiliated Hospital of China Medical Sciences University, Shenyang, Liaoning, China

Qinghai Provincial People'S Hospital, Xining, Qinghai, China

Qilu Hospital of Shangdong University, Jinan, Shandong, China

The Second Hospitalof Shangdong University, Jinan, Shandong, China

Huashan Hospital Fudan University, Shanghai, Shanghai, China

Shanghai Changzheng Hospital, Shanghai, Shanghai, China

West China Center of Medical Sciences, Chengdu, Sichuan, China

The General Hospital Under Tianjin Medical Sciences University, Tianjin, Tianjin, China

Tianjin Third Central Hospital, Tianjin, Tianjin, China

First Affiliated Hospital of Xinjiang Medical University, Uramuqi, Xinjiang uygur autonomous region, China

The First Affiliated Hospital of College of Medicine, Zhejiang University, Hangzhou, Zhejiang, China

Additional Information

Starting date: April 2008
Last updated: April 8, 2011

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017